Audrey Page

Title: Audrey Page: Innovator in Immunogenic Compositions

Introduction

Audrey Page is a notable inventor based in Villeurbanne, France. She has made significant contributions to the field of immunogenic compositions, particularly through her work with recombinant attenuated Mopeia virus. With a total of 2 patents, her innovations are paving the way for advancements in immune response therapies.

Latest Patents

Audrey Page's latest patents include:

1. **Immunogenic composition comprising a recombinant attenuated Mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity** - This patent describes a recombinant attenuated Mopeia virus (MOPV) that includes a genomic S segment encoding a nucleoprotein with attenuated exonuclease activity. It also optionally encodes a non-MOPV arenavirus glycoprotein, aimed at inducing an immune response in a subject.

2. **Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity** - Similar to her first patent, this invention focuses on a recombinant attenuated Mopeia virus that encodes a nucleoprotein with reduced exonuclease activity, also designed to induce an immune response in a subject.

Career Highlights

Audrey Page is affiliated with the prestigious Institut Pasteur, where she conducts her research and development. Her work is instrumental in advancing the understanding and application of viral vectors in immunology.

Collaborations

Audrey collaborates with talented individuals such as Alexandra Fizet and Xavier Carnec, contributing to a dynamic research environment that fosters innovation.

Conclusion

Audrey Page's contributions to the field of immunogenic compositions highlight her role as a leading inventor in the scientific community. Her patents reflect a commitment to advancing medical science and improving immune response therapies.